SCOTTSDALE, Ariz. — Karen Ozawa, a nurse practitioner with nineteen years behind her, sixteen of them in pediatric urgent care, keeps a ledger in which each patient occupies one row and each Tuesday occupies one number. The numbers have been getting smaller for two years. This is, by the arithmetic of her clientele, entirely the point.

Ms. Ozawa works at a longevity clinic on East Camelback Road, in a suite with pale green walls, a water feature, and a framed photograph of a desert sunset so ubiquitous in this industry that its absence would be the scandal. Her current procedure — the one that has patients driving in from Prescott — is the one-tenth dose: a fraction of a weekly weight-loss injection, drawn slow, stopped by counting, administered with the reverence of a sacrament.

Patients here are not treating obesity. A microdose of a GLP-1 drug means anything below the smallest approved dose, and it is being marketed not for the waistline but for the calendar — to tamp down inflammation, protect the brain, and slow aging itself. Telehealth companies have openly begun selling it that way, one longevity clinic advertising the practice as “a powerful new path to promoting long-term wellness.” No researcher in the field has said that sentence out loud about any human being.

Ms. Ozawa draws the doses with a one-milliliter tuberculin syringe — the small one, the careful one — and counts the seconds so the plunger stops at the same mark every week. “The medicine has a floor,” she says. “Below it, the studies stop talking. My patients want to live underneath the floor of the studies, and somebody should be the one person down there with a gauge.”

Her most devoted case is a retired 71-year-old pilot who long ago escalated past the clinic’s one-tenth into a self-directed one-hundredth, a home dilution he performs “the way I used to read a wind sock — small adjustments, big respect.” His bloodwork arrives at the clinic monthly whether he is dosing or not, because, he says, the number is now the hobby. When asked what he is optimizing for, he does not mention weight. “I’m not trying to lose weight,” he says. “I’m trying to lose years.”

The ledger runs to 187 rows. None of them include the word “proven.” The column for outcomes is dated, weekly, and honest: energy, sleep, appetite, marching distance, and — because Ms. Ozawa is the only person in this zip code keeping score at this scale — nothing else. The patients would say the ledger proves more than the trials do. Ms. Ozawa, who has read the trials, says the ledger proves she shows up.

The pilot’s one-hundredth dose arrives each Tuesday at 9:15 a.m. He counts it himself now, out loud, in the chair, while she holds the tray — both of them stopping at the same number. In this zip code, that counts as informed consent.